Earnings

Wave Life Sciences Anticipates $12M Milestone Payment From GSK In Q4

Oct 27, 2026 · 07:36 AM ET· updated 2h ago

Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced financial results for the third quarter

Why It Matters

Wave Life Sciences expects to receive $12 million from GSK soon. This money helps smaller biotech companies keep working on new medicines.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

WVE3.25

+0.04 (+1.25%)

GSK50.81

-0.29 (-0.57%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.